Prothena
PRTA
#6872
Rank
NZ$1.03 B
Marketcap
NZ$19.16
Share price
-0.81%
Change (1 day)
-20.37%
Change (1 year)

Market capitalization of Prothena (PRTA)

Market cap: NZ$1.03 Billion

As of December 2025 Prothena has a market cap of NZ$1.03 Billion. This makes Prothena the world's 6872th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Prothena from 2012 to 2025

End of year Market Cap

Year Marketcap Change
2025NZ$1.03 B-28.59%
2024NZ$1.44 B-53.16%
2023NZ$3.08 B-37.05%
2022NZ$4.89 B45.38%
2021NZ$3.36 B407.13%
2020NZ$0.66 B-29.14%
2019NZ$0.93 B53.21%
2018NZ$0.61 B-69.84%
2017NZ$2.02 B-17.13%
2016NZ$2.44 B-22.47%
2015NZ$3.15 B335.32%
2014NZ$0.72 B2.88%
2013NZ$0.70 B347.77%
2012NZ$0.15 B

End of Day market cap according to different sources

On Dec 6th, 2025 the market cap of Prothena was reported to be:

NZ$1.03 Billion
by Nasdaq info icon info icon
NZ$1.03 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Alkermes
ALKS
NZ$8.43 B 717.97%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Alnylam Pharmaceuticals
ALNY
NZ$104.76 B 10,056.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Amarin Corporation
AMRN
NZ$0.59 B-42.29%๐Ÿ‡ฎ๐Ÿ‡ช Ireland